[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

about

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

Item

http://www.wikidata.org/entity/Q55460811

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@en

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@nl

type

Item

label

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@en

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@nl

prefLabel

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@en

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

@nl

P1476

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors]

@en

P2093

J Schlegel

http://www.w3.org/2001/XMLSchema#string

U Schlegel

http://www.w3.org/2001/XMLSchema#string

W Stummer

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular subgroups of medulloblastoma: the current consensus

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

P2888

s00115-014-4122-7

P304

976-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-014-4122-7

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ghazaleh Tabatabai

Elke Hattingen

Ghazaleh Tabatabai

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029521457

http://www.w3.org/2001/XMLSchema#string

P698

25037494

http://www.w3.org/2001/XMLSchema#string